Medical Advisor｜ エンドルミナルソリューションズ

Graduated from Tohoku University School of Medicine in 1988; Doctor of Medicine.
After working at the Tohoku Rosai Hospital Department of Internal Medicine, Tohoku University Third Department of Internal Medicine, the Pathology Department of Tohoku University Hospital, and a fellowship at the National Cancer Institute (USA), he joined the Miyagi Cancer Society Cancer Check-up Center in 2004. He has served as the Director of the Cancer Check-up Center and Executive Director of the Miyagi Cancer Society since 2020.
His previous roles include Board Member of the Japanese Society of Gastrointestinal Cancer Screening, Advisor to the Gastric Cancer Screening Quality Assurance Committee, Chairperson of the Editorial Committee for the “Gastric Endoscopy Screening Manual for Population-based Screening (Revised Edition),” and Chairperson of the Editorial Committee for the “Radiographic Method Manual for Gastric X-ray Screening.”

— Comments on Our Products —

About 10 years have passed since gastric endoscopy was introduced as a public cancer control measure in Japan. Current gastric endoscopy screening is mainly operated through individual screenings utilizing the framework of insurance-covered medical care. While this ensures high diagnostic accuracy, it also places a heavy burden on regional medical resources.
Consequently, challenges such as capacity limits of the screening system, regional disparities in medical institutions, and high-cost structures have become apparent, leaving some areas unable to fully benefit.
The screening-specific disposable endoscopy system being developed by Endoluminal Solutions is expected to be an effective solution to the challenges of “throughput,” “accessibility,” and “economic efficiency” while maintaining sufficient performance for gastric cancer screening.
Once this system is implemented in society, it will expand the possibility of providing high-precision endoscopic screening as an alternative to gastric X-ray screening (barium tests), even in regions that have had to rely on group screenings via mobile buses.
There are high expectations for this system to realize a society where everyone can receive equally high-quality gastric cancer screening regardless of their region, while freeing examinees from the disadvantage of radiation exposure.

Graduated from Kobe University School of Medicine in 2001 and obtained a Doctor of Medicine in 2012.
He has accumulated clinical experience centered on diagnostic radiology and Interventional Radiology (IVR) at Osaka University Hospital and related facilities, engaging in a wide range of fields from diagnostic imaging to minimally invasive treatments.
In 2022, he was appointed Associate Professor of the Endowment Course of Image-guided High-precision Puncture Therapy, focusing on clinical practice, research, and education aimed at improving the precision and safety of image-guided treatments. In 2025, he was appointed Vice Director of the Radiology Department at Osaka University Hospital (and Director of the IVR Center), where he oversees department management and the development of the next generation of human resources in addition to medical care, education, and research.

— Comments on Our Products —
I have recently been appointed as a Medical Advisor for Endoluminal Solutions. As a physician specializing in diagnostic radiology, I have also been involved in health check-up medicine. Since gastric barium tests use X-rays, a single examination is said to involve dozens of times the radiation exposure of a chest X-ray. Health screenings are medical procedures that healthy individuals undergo repeatedly, leading to cumulative exposure. Given that the probability of future effects theoretically increases with cumulative dose, reconsidering the nature of screenings—now that non-radiological alternatives are being established—is an unavoidable challenge.
Endoscopic technology has advanced significantly over the past few decades and has reached a stage of maturity in terms of diagnostic accuracy, safety, and operational aspects. I believe that transitioning from radiation-dependent screenings to more rational and sustainable methods is a natural evolution of medicine. This project is a realistic effort to support that transition while addressing infection control and practical operational challenges. I have joined this project as a specialist with an eye toward the next stage of screening medicine.

After working for a management consulting firm, he has widely investigated medical device GLP tests, biological safety tests, and reliability standard tests for application documents as the head of the Reliability Assurance Department of a medical device industry support organization. He also has a track record in providing hands-on support for medical device development across Classes I to IV.
Regarding domestic and international regulations and quality standards, he is responsible for quality assurance across all processes, including design, development, manufacturing, sterilization, distribution, and post-market surveillance.